Heron Therapeutics, Inc. (HRTX)
After hours:
| Previous close | 1.4100 |
| Open | 1.4000 |
| Bid | 1.4400 x 3000 |
| Ask | 1.4900 x 4000 |
| Day's range | 1.3700 - 1.4900 |
| 52-week range | 0.5000 - 3.4100 |
| Volume | |
| Avg. volume | 2,959,684 |
| Market cap | 223.609M |
| Beta (5Y monthly) | 1.51 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.8800 |
| Earnings date | 14 Nov 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.63 |
Insider Monkey13 Hot Penny Stocks To Buy According to Hedge Funds
In this article, we will take a look at the 13 Hot Penny Stocks To Buy According to Hedge Funds. To see more hot penny stocks, go directly to 5 Hot Penny Stocks To Buy According to Hedge Funds. The overall market optimism helped by expectations that the Fed might start cutting interest rates in […]
Simply Wall St.CEO & Director of Heron Therapeutics Craig Collard Buys 411% More Shares
Investors who take an interest in Heron Therapeutics, Inc. ( NASDAQ:HRTX ) should definitely note that the CEO...
Insider MonkeyHeron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2023 Earnings Call Transcript
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2023 Earnings Call Transcript November 14, 2023 Heron Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.31. Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Q3 2023 Earnings Conference Call. As a reminder, this conference is being recorded. […]
